Fernanda Boulos has a PhD in Neuroimmunology from the Federal University of São Paulo (UNIFESP) and has more than 15 years of experience in clinical development in multinational companies, such as Pfizer and Novartis.
She is currently the medical director of the Butantan Institute, leading all ongoing clinical research at the institution.